secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALISADE BIO, INC. (PALI)
CIK:        0001357459
Form:       8-K
Filed at:   2022-08-16T23:59:59+00:00
Accession:  0000950170-22-017505
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Palisade Bio closes $13.8M underwritten public offering of common stock, Series B preferred, and warrants
--------------------------------------------------------------------------------

- Gross proceeds ~$13.8M; net proceeds ~$12.2M after underwriting discounts and estimated expenses.
- Issued 49.36M shares common, 1,460 shares Series B preferred (convertible into 4,000 common each), plus warrants for 55.2M shares at $0.25 exercise price.
- Underwriter's over-allotment option fully exercised for an additional 7.2M common shares and warrants.
- Warrants exercisable only after stockholder approval per Nasdaq rules; Series 1 expires in 1 year, Series 2 in 5 years.
- Post-offering outstanding common shares: 71,240,169 (excluding 5.84M shares from Series B conversion).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357459/000095017022017505/0000950170-22-017505-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357459/000095017022017505/pali-20220812.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-017505

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer